Unveiling a Ghost Proteome in the Glioblastoma Non-Coding RNAs

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma (GBM) is an aggressive adult brain cancer with a poor median survival rate of 15 months, even with standard treatments.
• Aberrant non-coding ribonucleic acid (ncRNA) expression is observed in GBM, impacting key cellular signaling pathways.
• A subset of ncRNAs can be translated into alternative proteins (AltProts), forming the 'ghost proteome' and potentially influencing GBM biology.

Purpose of the Study:

• To review the current understanding of ncRNAs implicated in glioblastoma.
• To highlight the functional roles of these ncRNAs and their derived AltProts in GBM pathogenesis.
• To emphasize the potential impact of ncRNAs and AltProts on patient prognosis and therapeutic strategies.

Main Methods:

• Literature review of studies investigating ncRNA expression and function in glioblastoma.
• Analysis of research on alternative protein (AltProt) translation from ncRNAs in GBM.
• Synthesis of findings related to ncRNA and AltProt involvement in GBM signaling, cellular processes, and clinical outcomes.

Main Results:

• ncRNAs and their AltProts are involved in protein-protein interactions with reference proteins, affecting signaling pathways crucial for GBM.
• These interactions are linked to cellular mobility and transfer RNA regulation, processes vital for tumor growth and metastasis.
• Emerging clinical evidence suggests AltProts derived from ncRNAs are associated with patient survival and prognosis in GBM.

Conclusions:

• ncRNAs and their translated AltProts represent a significant, yet understudied, component of glioblastoma.
• Further investigation into the ncRNA-AltProt axis is warranted to elucidate their precise roles in GBM.
• Targeting ncRNAs and AltProts may offer novel therapeutic avenues for improving glioblastoma patient outcomes.